Justine Telliez
Stock Analyst at Kepler Capital
(4.91)
# 230
Out of 4,408 analysts
354
Total ratings
52.9%
Success rate
55.2%
Average return
Main Sectors:
Stocks Rated by Justine Telliez
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | €5.50 | $3.19 | +72.52% | 26 | May 4, 2026 | |
| EPA: GBT Guerbet SA | Maintained: Hold | €13.80 | $9.81 | +40.67% | 24 | Apr 24, 2026 | |
| BIT: PHIL Philogen S.p.A. | Maintained: Buy | €34.00 | $23.00 | +47.83% | 1 | Apr 24, 2026 | |
| SWX: GALD Galderma Group AG | Maintained: Buy | CHF 167.00 | $172.95 | -3.44% | 12 | Apr 23, 2026 | |
| EPA: ADOC Adocia SA | Maintained: Buy | €12.00 | $4.40 | +172.73% | 26 | Apr 22, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €132.00 | $156.20 | -15.49% | 35 | Apr 22, 2026 | |
| EPA: ABVX ABIVAX Société Anonyme | Maintained: Buy | €130.00 | $85.10 | +52.76% | 33 | Apr 13, 2026 | |
| EPA: SIGHT GenSight Biologics S.A. | Maintained: Hold | €0.40 | $0.082 | +387.80% | 31 | Apr 8, 2026 | |
| EPA: GNFT Genfit S.A. | Maintained: Buy | €15.00 | $9.69 | +54.80% | 42 | Apr 7, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | $4.65 | -3.27% | 36 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €7.70 → €5.60 | $2.29 | +144.33% | 63 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €3.10 | $1.55 | n/a | 24 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.30 | $2.93 | n/a | 1 | Dec 1, 2023 |
DBV Technologies S.A.
May 4, 2026
Maintained: Buy
Price Target: €5.50
Current: $3.19
Upside: +72.52%
Guerbet SA
Apr 24, 2026
Maintained: Hold
Price Target: €13.80
Current: $9.81
Upside: +40.67%
Philogen S.p.A.
Apr 24, 2026
Maintained: Buy
Price Target: €34.00
Current: $23.00
Upside: +47.83%
Galderma Group AG
Apr 23, 2026
Maintained: Buy
Price Target: CHF 167.00
Current: $172.95
Upside: -3.44%
Adocia SA
Apr 22, 2026
Maintained: Buy
Price Target: €12.00
Current: $4.40
Upside: +172.73%
Ipsen S.A.
Apr 22, 2026
Maintained: Hold
Price Target: €132.00
Current: $156.20
Upside: -15.49%
ABIVAX Société Anonyme
Apr 13, 2026
Maintained: Buy
Price Target: €130.00
Current: $85.10
Upside: +52.76%
GenSight Biologics S.A.
Apr 8, 2026
Maintained: Hold
Price Target: €0.40
Current: $0.082
Upside: +387.80%
Genfit S.A.
Apr 7, 2026
Maintained: Buy
Price Target: €15.00
Current: $9.69
Upside: +54.80%
Idorsia Ltd
Mar 30, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: $4.65
Upside: -3.27%
Mar 26, 2026
Maintained: Buy
Price Target: €7.70 → €5.60
Current: $2.29
Upside: +144.33%
May 23, 2025
Maintained: Hold
Price Target: €3.10
Current: $1.55
Upside: n/a
Dec 1, 2023
Maintained: Buy
Price Target: €16.30
Current: $2.93
Upside: n/a